Dr. Ullal's clinical research interests include inpatient diabetes, Cystic Fibrosis-related endocrinopathies, and type 3c diabetes. Additional research interests include transplant diabetes, islet transplantation, diabetes technology, and electronic glucose management.
Dr. Ullal's clinical interests include Cystic Fibrosis endocrinology and diabetes, transplate-related diabetes, and total pancreatectomy followed by islet cell transplantation. His additional clinical interests include inpatient diabetes, thyroid cancer, thyroid ultrasonography, and thyroid biopsies. Dr. Ullal is the Co-Chair of the Diabetes Patient Safety Committee at UPMC Presbyterian Hospital.
Dr. Ullal is the Director of the Medical Student Clinical Experience in Inpatient Endocrinology, Diabetes, and Metabolism for the University of Pittsburgh School of Medicine (Course MED 5460). He is a faculty member in the Advanced Physical Examination Course for first and second year medical students and one of the faculty members involved in the Endocrine Disorders Course for medical students.
- MD, Kasturba Medical College, Mangalore, India (Manipal University), 1999
- MS, Biomedical Science Research, Eastern Virginia Medical School, 2004
- Mentor Based Research Fellowship, American Diabetes Association, Eastern Virginia Medical School, 2005
- Residency, Internal Medicine, Eastern Virginia Medical School, 2008
- Fellowship, Endocrinology, Diabetes and Metabolism, Eastern Virginia Medical School, 2010
Education & Training
Ullal, J., Dignan, C., Cwik, R., McFarland, R., Gaines, M., Aloi, J. A. Utility of Computer-Guided Decision Support System in Discharge Insulin Dosing and Diabetes-Related Readmissions. J Diabetes Sci Technol. 2021; 15(2): 523-524.
Ullal, J., Aloi, J. A. Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control. Curr Diab Rep. 2019; 19(11): 120.
Ullal, J., Aloi, J.A., Reyes-Umpierrez, D., Pasquel, F.J., McFarland, R., Rabinovich, M., Umpierrez, G.E. Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis. J Diabetes Sci Technol. 2018; 12(1): 39-46.
Khardori, R., Ullal, J., Lieb, D. C. Clinical Focus Series: Diabetus Mellitus. Jaypee Brothers Medical Publishers. 2018
Aloi, J., Bode, B.W., Ullal, J., Chidester, P., McFarland, R.S., Bedingfield, A.E., Mabrey, M., Booth, R., Mumpower, A., Wallia, A. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. J Diabetes Sci Technol. 2017; 11(1): 12-16.
Ullal, J., McFarland, R., Bachand, M., Aloi, J. Use of a Computer-Based Insulin Infusion Algorithm to Treat Diabetic Ketoacidosis in the Emergency Department. Diabetes Technol Ther. 2016; 18(2): 100-3.
Aloi, J.A., Mulla, C., Ullal, J., Lieb, D.C. Improvement in inpatient glycemic care: pathways to quality. Curr Diab Rep. 2015; 15(4): 18.
Vinik, A., Ullal, J., Parson, H. K., Casellini, C. M. Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab. 2006; 2(5): 269-81.
Vinik, A., Anandacoomaraswamy, D., Ullal, J. Antibodies to neuronal structures: innocent bystanders or neurotoxins?. Diabetes Care. 2005; 28(8): 2067-72.
- Fellowship of the American College of Endocrinology, 2014
- Fellowship of American College of Physicians, 2014
- Selected for AAMC’s 2016 Leadership and Management Foundations in Academic Medicine and Science Conference, Washington D.C., 2016
- 2017 Top Doctor Endocrinology-Coastal Virginia Magazine, 2017
- Cystic Fibrosis Foundation Funding: EnVision CF; Emerging Leaders in CF Endocrinology Program Funding, 2019-2022
